54.23
-0.66
(-1.20%)
At close: January 10 at 4:16:03 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 18 | 7 | 25 | 25 |
| Avg. Estimate | 11.53B | 11.48B | 47.46B | 46.7B |
| Low Estimate | 11.31B | 10.81B | 46.94B | 44.85B |
| High Estimate | 11.69B | 11.86B | 47.82B | 48.3B |
| Year Ago Sales | 11.48B | 11.87B | 45.01B | 47.46B |
| Sales Growth (year/est) | 0.50% | -3.27% | 5.45% | -1.61% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BRM.F | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 1/8/2025 |
| Upgrade | Jefferies: Hold to Buy | 12/16/2024 |
| Initiated | Wolfe Research: Peer Perform | 11/15/2024 |
| Maintains | Citigroup: Neutral to Neutral | 11/12/2024 |
| Maintains | BMO Capital: Market Perform to Market Perform | 11/12/2024 |
| Maintains | Morgan Stanley: Underweight to Underweight | 11/12/2024 |
Related Tickers
JNJ.CL Johnson & Johnson
619,740.00
+1.21%
0R34.IL Johnson & Johnson
143.00
+0.49%
LILY34.SA Eli Lilly and Company
162.20
+1.99%
GRF.MC Grifols, S.A.
9.06
-0.57%
NOV.DE Novo Nordisk A/S
84.60
-0.31%
NONOF Novo Nordisk A/S
85.80
0.00%
SNY Sanofi
48.73
-1.02%
MRK Merck & Co., Inc.
99.25
-0.60%
AZN AstraZeneca PLC
67.01
+0.65%
PFE Pfizer Inc.
26.72
-0.52%